On June 30, 2025, 4D Molecular Therapeutics, Inc. was dropped from several prominent Russell indices, including the Russell Microcap Growth Index, Russell 3000E Growth Index, Russell 2500 Growth Index, Russell 3000 Growth Index, and Russell 2000 Growth Index. These removals are part of the annual rebalancing process for the Russell family of indices.
Inclusion in these indices is often a factor for institutional investors, particularly those managing passive funds that track these benchmarks. Consequently, being dropped from multiple indices can trigger forced selling by such funds, potentially affecting the company's stock liquidity and trading volume.
While these changes are procedural and based on specific index criteria, they represent a notable shift in the company's market positioning within the broader investment community. Investors should be aware of the potential impact on the company's stock as index funds adjust their portfolios.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.